期刊
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
卷 23, 期 12, 页码 -出版社
MDPI
DOI: 10.3390/ijms23126367
关键词
neurodegenerative disorders; gut microbiota; antibiotic-induced intestinal injury; short-chain fatty acids; neuroinflammation
Recent evidence suggests that the initiation of Parkinson's disease occurs in the gut as a prodromal phase of neurodegeneration. The impairment of gut function due to microbial dysbiosis might influence the pathogenesis and progression of Parkinson's disease. In this study, a two-hit model of Parkinson's disease was proposed, which involved dysbiosis and gut inflammation induced by ceftriaxone, followed by intrastriatal injection of 6-hydroxydopamine to mimic the dysfunctional gut-associated mechanisms preceding the onset of Parkinson's disease. The findings demonstrated that dysbiosis and gut damage exacerbated the progression of Parkinson's disease, leading to worsening motor deficits induced by 6-hydroxydopamine.
Recent evidence highlights Parkinson's disease (PD) initiation in the gut as the prodromal phase of neurodegeneration. Gut impairment due to microbial dysbiosis could affect PD pathogenesis and progression. Here, we propose a two-hit model of PD through ceftriaxone (CFX)-induced dysbiosis and gut inflammation before the 6-hydroxydopamine (6-OHDA) intrastriatal injection to mimic dysfunctional gut-associated mechanisms preceding PD onset. Therefore, we showed that dysbiosis and gut damage amplified PD progression, worsening motor deficits induced by 6-OHDA up to 14 days post intrastriatal injection. This effect was accompanied by a significant increase in neuronal dopaminergic loss (reduced tyrosine hydroxylase expression and increased Bcl-2/Bax ratio). Notably, CFX pretreatment also enhanced systemic and colon inflammation of dual-hit subjected mice. The exacerbated inflammatory response ran in tandem with a worsening of colonic architecture and gut microbiota perturbation. Finally, we demonstrated the beneficial effect of post-biotic sodium butyrate in limiting at once motor deficits, neuroinflammation, and colon damage and re-shaping microbiota composition in this novel dual-hit model of PD. Taken together, the bidirectional communication of the microbiota-gut-brain axis and the recapitulation of PD prodromal/pathogenic features make this new paradigm a useful tool for testing or repurposing new multi-target compounds in the treatment of PD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据